APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Valsartan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchValsartan Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Valsartan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Drug Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Valsartan Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Valsartan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan Drug include Zhejiang Huahai Pharmaceutical, Teva, Sun Pharmaceutical, Novartis, Mylan, Huaren Pharmaceutical, Unichem Laboratories, Torrent Pharmaceuticals and Square Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan Drug Segment by Company

Zhejiang Huahai Pharmaceutical

Teva

Sun Pharmaceutical

Novartis

Mylan

Huaren Pharmaceutical

Unichem Laboratories

Torrent Pharmaceuticals

Square Pharmaceuticals

Macleods Pharmaceuticals

Lupin

Jubilant Pharma

HETERO

Aurobindo Pharma

Amneal Pharmaceuticals

Alembic Pharmaceuticals

Valsartan Drug Segment by Type

40 mg Tablets

80 mg Tablets

160 mg Tablets

320 mg Tablets

Valsartan Drug Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Valsartan Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Valsartan Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Valsartan Drug Industry Trends Table 2. Valsartan Drug Industry Drivers Table 3. Valsartan Drug Industry Opportunities and Challenges Table 4. Valsartan Drug Industry Restraints Table 5. Global Valsartan Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Valsartan Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Valsartan Drug Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Valsartan Drug Sales Market Share by Manufacturers Table 9. Global Valsartan Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Valsartan Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Valsartan Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Valsartan Drug Manufacturers, Product Type & Application Table 13. Global Valsartan Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 40 mg Tablets Table 17. Major Manufacturers of 80 mg Tablets Table 18. Major Manufacturers of 160 mg Tablets Table 19. Major Manufacturers of 320 mg Tablets Table 20. Global Valsartan Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Valsartan Drug Sales by Type (2021-2026) & (W Units) Table 22. Global Valsartan Drug Sales by Type (2027-2032) & (W Units) Table 23. Global Valsartan Drug Sales Market Share by Type (2021-2026) Table 24. Global Valsartan Drug Sales Market Share by Type (2027-2032) Table 25. Global Valsartan Drug Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 26. Global Valsartan Drug Revenue by Type (2021-2026) & (W Units) Table 27. Global Valsartan Drug Revenue by Type (2027-2032) & (W Units) Table 28. Global Valsartan Drug Revenue Market Share by Type (2021-2026) Table 29. Global Valsartan Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Heart Failure Table 31. Major Manufacturers of Heart Attack Table 32. Major Manufacturers of Hypertension Table 33. Global Valsartan Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Valsartan Drug Sales by Application (2021-2026) & (W Units) Table 35. Global Valsartan Drug Sales by Application (2027-2032) & (W Units) Table 36. Global Valsartan Drug Sales Market Share by Application (2021-2026) Table 37. Global Valsartan Drug Sales Market Share by Application (2027-2032) Table 38. Global Valsartan Drug Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Valsartan Drug Revenue by Application (2021-2026) & (W Units) Table 40. Global Valsartan Drug Revenue by Application (2027-2032) & (W Units) Table 41. Global Valsartan Drug Revenue Market Share by Application (2021-2026) Table 42. Global Valsartan Drug Revenue Market Share by Application (2027-2032) Table 43. Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Valsartan Drug Sales by Region (2021-2026) & (W Units) Table 45. Global Valsartan Drug Sales Market Share by Region (2021-2026) Table 46. Global Valsartan Drug Sales Forecasted by Region (2027-2032) & (W Units) Table 47. Global Valsartan Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 49. North America Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 50. North America Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 51. Europe Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. Europe Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 53. Europe Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 54. Asia Pacific Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Asia Pacific Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 56. Asia Pacific Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 57. South America, Middle East and Africa Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. South America, Middle East and Africa Valsartan Drug Sales by Country (2021-2026) & (W Units) Table 59. South America, Middle East and Africa Valsartan Drug Sales by Country (2027-2032) & (W Units) Table 60. Global Valsartan Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Valsartan Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Valsartan Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Valsartan Drug Revenue Market Share by Region (2021-2026) Table 64. Global Valsartan Drug Revenue Market Share by Region (2027-2032) Table 65. Zhejiang Huahai Pharmaceutical Company Information Table 66. Zhejiang Huahai Pharmaceutical Business Overview Table 67. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio Table 69. Zhejiang Huahai Pharmaceutical Recent Development Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Teva Valsartan Drug Product Portfolio Table 74. Teva Recent Development Table 75. Sun Pharmaceutical Company Information Table 76. Sun Pharmaceutical Business Overview Table 77. Sun Pharmaceutical Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sun Pharmaceutical Valsartan Drug Product Portfolio Table 79. Sun Pharmaceutical Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Novartis Valsartan Drug Product Portfolio Table 84. Novartis Recent Development Table 85. Mylan Company Information Table 86. Mylan Business Overview Table 87. Mylan Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Mylan Valsartan Drug Product Portfolio Table 89. Mylan Recent Development Table 90. Huaren Pharmaceutical Company Information Table 91. Huaren Pharmaceutical Business Overview Table 92. Huaren Pharmaceutical Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Huaren Pharmaceutical Valsartan Drug Product Portfolio Table 94. Huaren Pharmaceutical Recent Development Table 95. Unichem Laboratories Company Information Table 96. Unichem Laboratories Business Overview Table 97. Unichem Laboratories Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Unichem Laboratories Valsartan Drug Product Portfolio Table 99. Unichem Laboratories Recent Development Table 100. Torrent Pharmaceuticals Company Information Table 101. Torrent Pharmaceuticals Business Overview Table 102. Torrent Pharmaceuticals Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Torrent Pharmaceuticals Valsartan Drug Product Portfolio Table 104. Torrent Pharmaceuticals Recent Development Table 105. Square Pharmaceuticals Company Information Table 106. Square Pharmaceuticals Business Overview Table 107. Square Pharmaceuticals Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Square Pharmaceuticals Valsartan Drug Product Portfolio Table 109. Square Pharmaceuticals Recent Development Table 110. Macleods Pharmaceuticals Company Information Table 111. Macleods Pharmaceuticals Business Overview Table 112. Macleods Pharmaceuticals Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Macleods Pharmaceuticals Valsartan Drug Product Portfolio Table 114. Macleods Pharmaceuticals Recent Development Table 115. Lupin Company Information Table 116. Lupin Business Overview Table 117. Lupin Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Lupin Valsartan Drug Product Portfolio Table 119. Lupin Recent Development Table 120. Jubilant Pharma Company Information Table 121. Jubilant Pharma Business Overview Table 122. Jubilant Pharma Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Jubilant Pharma Valsartan Drug Product Portfolio Table 124. Jubilant Pharma Recent Development Table 125. HETERO Company Information Table 126. HETERO Business Overview Table 127. HETERO Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. HETERO Valsartan Drug Product Portfolio Table 129. HETERO Recent Development Table 130. Aurobindo Pharma Company Information Table 131. Aurobindo Pharma Business Overview Table 132. Aurobindo Pharma Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Aurobindo Pharma Valsartan Drug Product Portfolio Table 134. Aurobindo Pharma Recent Development Table 135. Amneal Pharmaceuticals Company Information Table 136. Amneal Pharmaceuticals Business Overview Table 137. Amneal Pharmaceuticals Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Amneal Pharmaceuticals Valsartan Drug Product Portfolio Table 139. Amneal Pharmaceuticals Recent Development Table 140. Alembic Pharmaceuticals Company Information Table 141. Alembic Pharmaceuticals Business Overview Table 142. Alembic Pharmaceuticals Valsartan Drug Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Alembic Pharmaceuticals Valsartan Drug Product Portfolio Table 144. Alembic Pharmaceuticals Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Valsartan Drug Distributors List Table 148. Valsartan Drug Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Valsartan Drug Product Image Figure 2. Global Valsartan Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Drug Sales (2021-2032) & (W Units) Figure 5. Global Valsartan Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Valsartan Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 40 mg Tablets Image Figure 9. 80 mg Tablets Image Figure 10. 160 mg Tablets Image Figure 11. 320 mg Tablets Image Figure 12. Global Valsartan Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Valsartan Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Drug Sales Market Share by Type (2021-2032) Figure 15. Global Valsartan Drug Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Valsartan Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Valsartan Drug Revenue Market Share by Type (2021-2032) Figure 18. Heart Failure Image Figure 19. Heart Attack Image Figure 20. Hypertension Image Figure 21. Global Valsartan Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Valsartan Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Valsartan Drug Sales Market Share by Application (2021-2032) Figure 24. Global Valsartan Drug Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Valsartan Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Valsartan Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 28. North America Valsartan Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Canada Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Mexico Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Europe Valsartan Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 35. France Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 36. U.K. Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Italy Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Netherlands Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Asia Pacific Valsartan Drug Sales Market Share by Country (2021-2032) Figure 41. China Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Japan Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 43. South Korea Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Southeast Asia Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 45. India Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Australia Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South America, Middle East and Africa Valsartan Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South Africa Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Saudi Arabia Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Turkey Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Argentina Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 54. UAE Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Egypt Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Chile Valsartan Drug Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Global Valsartan Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Valsartan Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Valsartan Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Valsartan Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Valsartan Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Valsartan Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Valsartan Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Valsartan Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 40 mg Tablets
  • 80 mg Tablets
  • 160 mg Tablets
  • 320 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Huaren Pharmaceutical
  • Unichem Laboratories
  • Torrent Pharmaceuticals
  • Square Pharmaceuticals
  • Macleods Pharmaceuticals
  • Lupin
  • Jubilant Pharma
  • HETERO
  • Aurobindo Pharma
  • Amneal Pharmaceuticals
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Valsartan Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Valsartan Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Valsartan Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Valsartan Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Valsartan Drug Market Dynamics
  1. 2.1 Valsartan Drug Industry Trends
  2. 2.2 Valsartan Drug Industry Drivers
  3. 2.3 Valsartan Drug Industry Opportunities and Challenges
  4. 2.4 Valsartan Drug Industry Restraints
3 Valsartan Drug Market by Manufacturers
  1. 3.1 Global Valsartan Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Valsartan Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Valsartan Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Valsartan Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Valsartan Drug Manufacturers, Product Type & Application
  7. 3.7 Global Valsartan Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Drug Tier 1, Tier 2, and Tier 3
4 Valsartan Drug Market by Type
  1. 4.1 Valsartan Drug Type Introduction
  2. 4.1.1 40 mg Tablets
  3. 4.1.2 80 mg Tablets
  4. 4.1.3 160 mg Tablets
  5. 4.1.4 320 mg Tablets
  6. 4.2 Global Valsartan Drug Sales by Type
  7. 4.2.1 Global Valsartan Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Valsartan Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Valsartan Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Valsartan Drug Revenue by Type
  11. 4.3.1 Global Valsartan Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Valsartan Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Valsartan Drug Revenue Market Share by Type (2021-2032)
5 Valsartan Drug Market by Application
  1. 5.1 Valsartan Drug Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Heart Attack
  4. 5.1.3 Hypertension
  5. 5.2 Global Valsartan Drug Sales by Application
  6. 5.2.1 Global Valsartan Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Valsartan Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Valsartan Drug Revenue by Application
  10. 5.3.1 Global Valsartan Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Valsartan Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Valsartan Drug Revenue Market Share by Application (2021-2032)
6 Global Valsartan Drug Sales by Region
  1. 6.1 Global Valsartan Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Valsartan Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Valsartan Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Valsartan Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Valsartan Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Valsartan Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Valsartan Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Valsartan Drug Revenue by Region
  1. 7.1 Global Valsartan Drug Revenue by Region
  2. 7.1.1 Global Valsartan Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Valsartan Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Valsartan Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Valsartan Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Valsartan Drug Revenue (2021-2032)
  8. 7.2.2 North America Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Valsartan Drug Revenue (2021-2032)
  11. 7.3.2 Europe Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Valsartan Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Valsartan Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Valsartan Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Valsartan Drug Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Valsartan Drug Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Valsartan Drug Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Valsartan Drug Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Huaren Pharmaceutical
  32. 8.6.1 Huaren Pharmaceutical Company Information
  33. 8.6.2 Huaren Pharmaceutical Business Overview
  34. 8.6.3 Huaren Pharmaceutical Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huaren Pharmaceutical Valsartan Drug Product Portfolio
  36. 8.6.5 Huaren Pharmaceutical Recent Developments
  37. 8.7 Unichem Laboratories
  38. 8.7.1 Unichem Laboratories Company Information
  39. 8.7.2 Unichem Laboratories Business Overview
  40. 8.7.3 Unichem Laboratories Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Unichem Laboratories Valsartan Drug Product Portfolio
  42. 8.7.5 Unichem Laboratories Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Valsartan Drug Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Square Pharmaceuticals
  50. 8.9.1 Square Pharmaceuticals Company Information
  51. 8.9.2 Square Pharmaceuticals Business Overview
  52. 8.9.3 Square Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Square Pharmaceuticals Valsartan Drug Product Portfolio
  54. 8.9.5 Square Pharmaceuticals Recent Developments
  55. 8.10 Macleods Pharmaceuticals
  56. 8.10.1 Macleods Pharmaceuticals Company Information
  57. 8.10.2 Macleods Pharmaceuticals Business Overview
  58. 8.10.3 Macleods Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Macleods Pharmaceuticals Valsartan Drug Product Portfolio
  60. 8.10.5 Macleods Pharmaceuticals Recent Developments
  61. 8.11 Lupin
  62. 8.11.1 Lupin Company Information
  63. 8.11.2 Lupin Business Overview
  64. 8.11.3 Lupin Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lupin Valsartan Drug Product Portfolio
  66. 8.11.5 Lupin Recent Developments
  67. 8.12 Jubilant Pharma
  68. 8.12.1 Jubilant Pharma Company Information
  69. 8.12.2 Jubilant Pharma Business Overview
  70. 8.12.3 Jubilant Pharma Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jubilant Pharma Valsartan Drug Product Portfolio
  72. 8.12.5 Jubilant Pharma Recent Developments
  73. 8.13 HETERO
  74. 8.13.1 HETERO Company Information
  75. 8.13.2 HETERO Business Overview
  76. 8.13.3 HETERO Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 HETERO Valsartan Drug Product Portfolio
  78. 8.13.5 HETERO Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Valsartan Drug Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Amneal Pharmaceuticals
  86. 8.15.1 Amneal Pharmaceuticals Company Information
  87. 8.15.2 Amneal Pharmaceuticals Business Overview
  88. 8.15.3 Amneal Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amneal Pharmaceuticals Valsartan Drug Product Portfolio
  90. 8.15.5 Amneal Pharmaceuticals Recent Developments
  91. 8.16 Alembic Pharmaceuticals
  92. 8.16.1 Alembic Pharmaceuticals Company Information
  93. 8.16.2 Alembic Pharmaceuticals Business Overview
  94. 8.16.3 Alembic Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Alembic Pharmaceuticals Valsartan Drug Product Portfolio
  96. 8.16.5 Alembic Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan Drug Value Chain Analysis
  2. 9.1.1 Valsartan Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan Drug Production Mode & Process
  6. 9.2 Valsartan Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan Drug Distributors
  9. 9.2.3 Valsartan Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst